Simon Chandler

How do growth factors produce cell division? Growth factors promote cell proliferation by initiating a chain of events when they bind to their receptors, which ripple through the cell. Our latest blog article explains these events. https://lnkd.in/eSS-qsjS

17

I am incredibly proud to announce that we have been awarded a £1.6M project from Innovate UK’s Biomedical Catalyst 2023 Round 2: Industry-led R&D 🙌 This application took a tremendous amount of effort, including working well into the early hours of many mornings to perfect the initial submission and cancelling leave over Christmas to prepare for the interview stage. Innovate UK grants (rightly!) require significant work; the application is scrutinised by five experienced assessors from various areas across Life Sciences. The next-stage interview is then attended by up to ten other people, with our panel including professionals from the NHS, academia, and CDMOs, among others. With a pot of £17.8M, and average project cost at £415,191, only 30 of the 358 applications could be funded 💰 . It is therefore truly gratifying to have so many experts agree that the cause we are developing solutions for is important and worthy of this substantial investment ✊ We do not take this funding lightly and will work tirelessly to ensure the success of our exciting project. Time to get cracking! https://lnkd.in/ev58aTt8 #biomedicalcatalyst #healthcare #infantmicrobiome #microbiome #grantfunding #grants #investment #innovateuk #biotech

463

54 Comments

Are you a #biotech or #healthinnovation company looking to #raisefunds? Can you be in #London on 4th December 2024?? Are you interested in meeting a mixture of US and European Investors??? If you answer yes, please read on! RESI London 2024 is the most cost-effective opportunity you will get to attend such a high-quality, high-engagement and high-value event full of investors. What's more, it's in the UK, so for many of our #AgileLeaders network, not too far to travel! The folks at Life Science Nation are world-renowned for their #RESI investment conferences. This #RESILondon investor conference is in collaboration with One Nucleus's Genesis conference. The RESI London event merges with the #GenesisLondon 2024 at 4.30 pm on the 4 December for further networking. The venues are less than 5 minutes walk away from each other at the King's Fund on Cavendish Square and the Royal Medical Society at 1 Wimpole Street respectively. This event activity is terrific for #lifesciences in the #UK and we expect it to boost #earlystage investment for the #UK community. What's more, by using the code AgileLeaders15 you get 15% off these already great attendance rates!!! Qualified Investors go for free, so go to the RESI website to register for free if you're a qualified investor - no investment consultants or non-qualified non-professional investors need to apply. Stringent vetting is applied to all free investor applications. What RESI do exceptionally well is have qualified information on all their #investors attending so you can tell on the partnering system if they are potentially the right investor for you, or not. Typically these #RESI events have a 50:50 ratio of investors to #innovationcompanies, and this London event will be no exception. If you are a #drug, #device, #diagnostic or #digitalhealth #innovation company looking for #funding, this is a “must attend” event.  To register visit the RESI London website now to get this great 15% off deal using the AgileLeaders15 discount code. You won't get a better deal anywhere else. Space is limited, so I suggest you book your ticket ASAP to avoid any disappointment: https://lnkd.in/eSEnayPD Sponsorship Opportunities: If you are a service company, law firm or consultancy firm wanting to mix and be visible with these emerging innovation company CXOs and investors, there are some brilliant sponsorship options too, so get in touch if you are interested. For example there is an exhibitor and logo sponsorship package available for only £1,500 with two delegates, which I hope you agree is terrific value.

4

https://lnkd.in/eMnPdwZs Read the latest blog on the comparison of molecular detection Techniques: SYBR Green Vs. TaqMan written by our expert Product Manager John Probert at 2BScientific Ltd. #TaqMan and #SYBR Green #PCR techniques are critical for research in molecular biology, driving advancements in investigations and diagnostics. Here’s why they're essential: Gene Expression Analysis and Biomarker Detection: SYBR Green PCR for screening, followed by TaqMan PCR for precise quantification and validation. Microbial Detection and Oncology: SYBR Green PCR for broad screening, TaqMan PCR for accurate quantification of specific targets. Epigenetics Studies, Pharmacogenomics, and Personalised Medicine: SYBR Green PCR's early assessment complements TaqMan PCR's precision, aiding informed treatment decisions. Check out the detailed article from 2BScientific covering the utilisation of TaqMan and SYBR Green, along with our selection of superior research reagents suitable for PCR and various research applications. #hereforyou #2bscientific #molecular

7

This is such an important subject and a big thanks to British In Vitro Diagnostics Association (BIVDA) for raising it at a Parliamentary Reception this week. Getting innovations into the NHS is challenging, especially for SMEs who have limited resources and significant pressures from their investors to get sales. One of the unfortunate consequences of this is that SMEs are forced to focus their efforts on larger international markets with quicker pathways to adoption, and UK patients cannot access homegrown innovations. Surely there must be a way to reduce the barriers to adoption to ensure British innovations are available in their home market first? #skincancer #melanoma #diagnostic # innovation #AMBLor

24

1 Comment

Rapid, detailed cell analysis technology soon ready to assess the difference it can make to process insights and timelines

11

🙌…and therapy developers push even harder to implement our revolutionary Celledonia™️ cell analyser at scale. 🏴󠁧󠁢󠁳󠁣󠁴󠁿An homage to Caledonia squared to the power of Celidonius (“a man born blind whom Jesus healed in the Gospel of John 9:1–38”): AuraCyt empowers our industry to finally “See the Unseen”… 1️⃣ predicting the unpredictable: high-producing clones in Cell Line Development - saving 3-6 crucial months in that process, every single time; 🧫 2️⃣ enabling scale-out of CGT to manufacture the unmanufacturable; 🧬 3️⃣ unlocking automation with rapid cell analysis for direct CGT process control;⏰ https://lnkd.in/e_bPw6Wz https://lnkd.in/eUE2Fhdw #CellAnalysis game-changer 👾| #CellAndGene | #CGT 🧬| #AdvancedTherapies 🧪 #SpeedToMarket 🏁 | #SpeedToPatient 👩‍🔬⌛️👨‍🔬

22

Source LDPath (a part of Source BioScience) has published a new white paper offering a comprehensive analysis of the challenges and opportunities in NHS digital pathology. Drawing on insights from leading stakeholders across the UK, the publication delves into the practical aspects of histopathology service delivery and outlines a strategic approach to accelerating digital transformation. Designed to complement existing NHS initiatives, it provides actionable guidance to address key barriers and support seamless integration into current systems. The paper offers a roadmap for advancing digital pathology, featuring proven strategies for department-wide implementation and practical recommendations to drive large-scale success. By addressing both the obstacles and opportunities, it aims to transform the delivery of histopathology services within the NHS, enabling more efficient and effective care. Find out more on Pathology News: https://lnkd.in/gPNH-iEF #digitalpathology #pathologynews

13

1 Comment

Antimicrobial Resistance (AMR) is a serious threat to global public health. The UK government has recently announced a new action plan to combat AMR, which includes support for industries to develop new treatments. I believe that a similar action plan is needed in India. AMR is a major problem in India, and it is essential that we take steps to address it. The Indian government should provide support to industries for the development of new treatments and diagnostics for AMR. This could include financial incentives, such as tax breaks or grants, as well as regulatory support, such as fast-tracking the approval process for new drugs/diagnostics. Organisations like Biotechnology Industry Research Assistance Council (BIRAC) are already doing it, but more is needed. The government and industries should also work to raise awareness of AMR among the public and healthcare professionals. This could be done through public health campaigns and educational programs. #publichealth #amr #policy Module Innovations

11

Are you a manufacturer of Digital Therapeutics (DTx) with a focus on the UK market? In this blog post, we delve into the intricacies of Digital Therapeutics (DTx) regulation in the UK, especially in light of Brexit in January 2020. 👉 https://lnkd.in/eqYb38ZF #DTx #DigitalTherapeutics #RegulatoryAffairs #Brexit

11

Do you know how growth factors can cause a cell to differentiate and change function? We explain in our weekly blog: https://lnkd.in/etAqwuX7

3

Fantastic set of talks today highlighting the unsung hero of drug discovery - Enzymology. Sincere thanks to Argyrides Argyrou , Claire McWhirter and Karl Syson for organising such a valuable and engaging symposium, AstraZeneca for hosting and all the speakers for their fantastic presentations! Really important topics discussed including the non-equilibrium environment of biological systems and the requirement for drug and target to be bound in order to have an effect, and the risks of using oversimplified metrics to support programme progression (from simply underestimating affinity through to fundamentally flawed selections). Data is of critical importance to effectively power decision-making and context is key. With the evolving ecosystem of instrumentation (including BMG LABTECH, SPT Labtech, FORMULATRIX, Tecan) reagents (including Cisbio, Revvity, Promega UK) and analytical capabilities (Genedata, GraphPad Prism) all now delivering the quality and consistency required to deliver the data resolution required, these concepts are becoming more readily accessible. Reflecting on the morning session over lunch highlights to me the still largely untapped potential of kinetic information. As an industry, we have been here before, discussing the advances in capabilities and significant merits on offer. However, this has largely been to an audience that is already receptive and uptake has remained pretty flat. So, how do we shift the dial? My personal view is that success is inextricably connected to more effective communication - I will expand on this concept in a future post. However, I’d love to hear your ideas on how you think we should tackle the challenges we face in translating untapped potential into tangible value. Please leave your thoughts below ⬇️ and follow/connect with me if you are keen to contribute to the discussion! #enzymology #kinetics #futuresuccess

84

6 Comments

Are you a #biotech or #healthinnovation company looking to raise funds? Can you be in #London on 4th December 2024?? Are you interested in meeting a mixture of qualified US and European Investors??? If you answer yes, please read on! #RESILondon24 is the most cost-effective opportunity to attend such a high-quality, high-engagement and high-value event full of investors. What's more, it's in the #UK, so for many of our #AgileLeaders network, not too far to travel. The folks at Life Science Nation are world-renowned for their #RESI investment conferences. This #RESILondon investor conference is in collaboration with One Nucleus's Genesis conference. The #RESILondon event merges with the #GenesisLondon24 at 4.30 pm on the 4 December for further networking. The venues are less than 5 minutes walk away from each other at The King's Fund on Cavendish Square and the Royal Society of Medicine at 1 Wimpole Street respectively. This activity is terrific for #lifesciences in the #UK and we expect #RESILondon will help to boost #earlystage investment for the UK community. What's more, by using the discount code AgileLeaders15 you get 15% off these already great attendance rates!!! Qualified Investors go for free, so go to the RESI website to register for free if you're a qualified investor - no investment consultants or non-qualified non-professional investors need to apply. Stringent vetting is applied to all free investor applications. What #RESI do exceptionally well, compared to other investor conferences, is have qualified information on all their #investors attending so you can tell on the partnering system if they are potentially the right investor for you or not. Typically these #RESI events have a 50:50 ratio of investors to #innovationcompanies, and this London event will be no exception. If you are a #drug, #device, #diagnostic or #digitalhealth #innovation company visit the #RESILondon website now to get this great 15% off deal using the AgileLeaders15 discount code. You won't get a better deal anywhere else. Space is limited, so I suggest you book your ticket ASAP to avoid any disappointment: https://lnkd.in/eSEnayPD If you have any questions about #RESILondon or #GenesisLondon24 and how they work together, don't hesitate to contact me. I'm already looking forward to 4 December. Will we see you there, too? #lifesciences #medtech #diagnostics #biotechbuddies #raisingcapital #investorcollisions #showmethemoney

13

SMALL CAP IDEA: Time to add Hemogenyx Pharma to the watchlist https://lnkd.in/e5xWgbha

19

⚡ Make Transformation easy ⚡ #Microbiology #Labs in the UK and Ireland today are transforming their models of delivery enabling responsive, better-quality services. This aids earlier #diagnosis, improving patient outcomes. However, recruitment and retention of staff remains a significant challenge for #Pathology services. In the #UK and #Ireland, bioMérieux have a local, dedicated team of Laboratory Consultants who are Specialists in Microbiology. We take the time to understand you. 💡 Our Lab Consultants bring bioMérieux’s 60 years of Microbiology expertise and #innovation to adapt and design your solution around your precise needs, set up and workflow. Not only that, but we empower and support your staff to ease them into their new ways of working through our fun and engaging change management workshops. We understand your services never stand still and foster continued innovation within our #partnerships. We will empower your staff throughout our partnership by offering access to our #ChangeManagement and #ConsultancyServices, career development opportunities and learning and development support tools to help your services attract and retain the best talent.  #beagamechanger bioMérieux Clinical Diagnostics (IVD) Chantal Cyman

4

Thrilled to be part of the team creating an AI-powered tool for drug discovery! 🧬🔍 As a statistician, I'm excited to contribute to a solution that will impact so many lives. Let's harness the power of AI to revolutionize medicine together! 💊💡 #DrugDiscovery #AI #Revivocell #Statistics"

9

Check out the key highlights from our recently released CGT Catapult Annual Review 2024 in the video below 👇 Read the Annual Review 2024: https://ow.ly/MA8k50ThbHZ #CellTherapy #GeneTherapy #AdvancedTherapies

21

1 Comment

Are you a #biotech or #healthinnovation company looking to raise funds? Can you be in #London on 4th December 2024?? Are you interested in meeting a mixture of US and European Investors??? If you answer yes, please read on! RESI London 2024 is the most cost-effective opportunity to attend such a high-quality, high-engagement and high-value event full of investors. What's more, it's in the UK, so for many of our #AgileLeaders network, not too far to travel!  If you use the Discount Code AgileLeaders15 you will get a 15% discount from the advertised rates. Visit the RESI London website for more details and to register. https://lnkd.in/eSEnayPD Sponsorship Opportunities If you are a service company, law firm or consultancy firm wanting to mix and be visible with these emerging innovation company CXOs and investors, there are some brilliant sponsorship options, so get in touch if you are interested. For example, an exhibitor and logo sponsorship package is available for only £1,500 with two delegates, which I hope you agree is of terrific value. #lifesciences #london #biotech #medtech #diagnostics #digitalhealth #biopharma #fundraising #investor #investment

4

Alongside the ever-growing complexity of drugs, the introduction of AI has added additional complexity to the biotech manufacturing landscape. For many, this complexity is overwhelming and becoming increasingly difficult to navigate. Partnering with a CDMO allows biotech and pharmaceutical companies to take advantage of specialised expertise, making it easier to navigate the changing world of manufacturing. This can help accelerate your product's development whilst avoiding regulatory hurdles. At evitria, we pride ourselves on supporting the antibody production process and seek to use our expertise to collaborate closely with our clients. We also partner with several other CDMOs, giving you access to highly tailored support to ensure success. #AntibodyExpression #Pharmaceuticals #CDMOs #Biotech

8